Literature DB >> 6801660

Establishment and characterization of human T hybrid cells secreting immunoregulatory molecules.

M Okada, N Yoshimura, T Kaieda, Y Yamamura, T Kishimoto.   

Abstract

Hybridization of human T cells with an azaguanine-resistant human T cell line gave rise to T hybrid cell lines secreting several immunoregulatory molecules. Analyses of karyotypes, HLA phenotypes, and other surface phenotypes, such as T-cell-specific antigens or receptors for sheep erythrocytes and the patterns of mitogen responsiveness confirmed that the hypoxanthine/aminopterin/thymidine-resistant cell lines were human T-T hybridomas. One of the established hybrid clones (24-A) secreted human interleukin-2 (IL-2). The culture supernatants induced the proliferation of concanavalin A-stimulated murine T cells and supported the proliferation of an IL 2-dependent human cytotoxic T-cell line. In a clone (38-B) that did not show any IL-2 activity in culture supernatants, the addition of macrophages induced IL-2 production in the presence of phytohemagglutinin, suggesting that interleukin-1 induced IL-2 production in T hybrid cells. Hybrid cells secreting killer helper factor were also established. The culture supernatants from this clone, 55-A, helped the induction of cytotoxic T cells against UV-treated human B-blastoid cells but did not show any IL-2 activity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6801660      PMCID: PMC349341          DOI: 10.1073/pnas.78.12.7717

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  LPS-or 8Br-cyclic AMP-induced production of T cell-activating factor(s) in macrophage tumor cell line J774.1.

Authors:  M Okada; T Kishimoto; T Igarashi; T Teranishi; Y Yamamura
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

2.  In vitro immune response of human peripheral lymphocytes. I. The mechanism(s) involved in T cell helper functions in the pokeweed mitogen-induced differentiation and proliferation of B cells.

Authors:  T Hirano; T Kuritani; T Kishimoto; Y Yamamura
Journal:  J Immunol       Date:  1977-10       Impact factor: 5.422

3.  Partial purification and molecular characterization of a lymphokine (costimulator) required for the mitogenic response of mouse thymocytes in vitro.

Authors:  J Shaw; V Monticone; V Paetkau
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

4.  Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2.

Authors:  W L Farrar; H M Johnson; J J Farrar
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

5.  Antigen-induced T cell-replacing factor (TRF). III. Establishment of T cell hybrid clone continuously producing TRF and functional analysis of released TRF.

Authors:  K Takatsu; K Tanaka; A Tominaga; Y Kumahara; T Hamaoka
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

6.  T-Cell lymphoma model for the analysis of interleukin 1-mediated T-cell activation.

Authors:  S Gillis; S B Mizel
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

7.  The role of interleukin-2 (IL-2) in the differentiatin of cytotoxic T cells: the effect of monoclonal anti-IL-2 antibody and absorption with IL-2 dependent T cell lines.

Authors:  D E Kern; S Gillis; M Okada; C S Henney
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

8.  The differentiation of cytotoxic T cells in vitro. IV. Interleukin-2 production in primary mixed lymphocyte cultures involves cooperation between Qa-1+ and Qa-1- "helper" T cells.

Authors:  M Okada; T H Stanton; R C Kuppers; C S Henney
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

9.  Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line.

Authors:  S Gillis; J Watson
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

10.  Epstein-barr virus-negative human malignant T-cell lines.

Authors:  J Kaplan; T C Shope; W D Peterson
Journal:  J Exp Med       Date:  1974-05-01       Impact factor: 14.307

View more
  27 in total

1.  The study of novel DNA vaccines against tuberculosis: induction of pathogen-specific CTL in the mouse and monkey models of tuberculosis.

Authors:  Masaji Okada; Yoko Kita; Toshihiro Nakajima; Satomi Hashimoto; Hitoshi Nakatani; Shiho Nishimatsu; Yasuko Nishida; Noriko Kanamaru; Yasuhumi Kaneda; Yasushi Takamori; David McMurray; Esterlina V Tan; Marjorie L Cang; Paul Saunderson; E C Dela Cruz
Journal:  Hum Vaccin Immunother       Date:  2012-12-18       Impact factor: 3.452

2.  Production of bovine immunoregulatory molecules by xenogeneic hybrids.

Authors:  R A Collins; B V Jones; G Oldham
Journal:  Immunology       Date:  1990-10       Impact factor: 7.397

3.  Regulation of human B-cell activation, proliferation, and differentiation by soluble factors.

Authors:  A Muraguchi; J H Kehrl; J L Butler; A S Fauci
Journal:  J Clin Immunol       Date:  1984-09       Impact factor: 8.317

4.  Production of functional human T-T hybridomas in selection medium lacking aminopterin and thymidine.

Authors:  S K Foung; D T Sasaki; F C Grumet; E G Engleman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

5.  Preclinical study and clinical trial of a novel therapeutic vaccine against multi-drug resistant tuberculosis.

Authors:  Masaji Okada; Yoko Kita; Satomi Hashimoto; Hitoshi Nakatani; Shiho Nishimastu; Yumiko Kioka; Yasuko Takami
Journal:  Hum Vaccin Immunother       Date:  2016-12-14       Impact factor: 3.452

6.  Novel therapeutic vaccines [(HSP65 + IL-12)DNA-, granulysin- and Ksp37-vaccine] against tuberculosis and synergistic effects in the combination with chemotherapy.

Authors:  Yoko Kita; Satomi Hashimoto; Toshihiro Nakajima; Hitoshi Nakatani; Shiho Nishimatsu; Yasuko Nishida; Noriko Kanamaru; Yasuhumi Kaneda; Yasushi Takamori; David McMurray; Esterlina V Tan; Marjorie L Cang; Paul Saunderson; E C Dela Cruz; Masaji Okada
Journal:  Hum Vaccin Immunother       Date:  2012-12-18       Impact factor: 3.452

7.  Formation of IgE-binding factors by human T-cell hybridomas.

Authors:  T F Huff; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

8.  Antigen-specific human T-cell hybridomas with helper activity.

Authors:  E C DeFreitas; S Vella; A Linnenbach; C Zmijewski; H Koprowski; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

9.  Lysis of fresh human solid tumor cells by autologous lymphocytes activated in vitro by allosensitization.

Authors:  A Mazumder; E A Grimm; S A Rosenberg
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

10.  Characterization of a human X mouse T cell hybridoma and identification of a clone secreting and binding interleukin-2.

Authors:  L G Durrant; M Parkar; N Kenworthy; G M Taylor
Journal:  Immunology       Date:  1984-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.